RECONFIRM - Study of AGN1 LOEP in Patients with Osteoporosis

Key facts

Sponsor

AgNovos Healthcare, LLC

Principal Investigator

Jo De Schepper, MD

AZ Nikolaas

Intervention

AGN1 LOEP(device)

Enrollment

150 enrolled

Eligibility

FEMALE

Timeline

2021 – 2026

Study locations (1)

• AZ Nikolaas, Sint-Niklaas, Antwerpen, Belgium

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Becker muscular dystrophy

Additional recruiting or active studies for the same condition.

• ENROLLING BY INVITATIONNCT07565272
  Usability and User Experience of a Virtual Reality Rehabilitation Game Platform in Individuals With Duchenne Muscular Dystrophy
  Istanbul University
• ENROLLING BY INVITATIONNANCT07543302
  Can External Vagus Nerve Stimulation Reduce Systemic Levels of Inflammatory Mediators in Duchenne Muscular Dystrophy Patients?
  taVNS AB
• RECRUITINGNCT07515235
  DMD Gene Variants and Cardiac Dysfunction in Young Males With Dystrophinopathies
  Aristotle University Of Thessaloniki
• RECRUITINGNANCT07415421
  Parathyroidectomy After Kidney Transplantation
  Aarhus University Hospital
• ACTIVE NOT RECRUITINGNCT07519720
  An Assessment of Risk Factors for Osteosarcopenia in Older Adults - the Role of Prevention, Lifestyle, Physical Activity and Education.
  Wroclaw University of Health and Sport Sciences
• ENROLLING BY INVITATIONPHASE1NCT07178327
  Phase I Clinical Study to Assess Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of LYN101
  Shanghai TTM-Bio Technology Co., Ltd
• RECRUITINGNCT07565051
  Can Pre-operative Lean Mass Predict Weight Loss After Roux-en-Y Gastric Bypass?
  University Hospital, Geneva
• RECRUITINGNANCT06949280
  Metabolic Health, Bones and Nuts During Weight Loss in Adults
  Rutgers, The State University of New Jersey

See all trials for Becker muscular dystrophy →